Interaction of Complement Factor H and Fibulin3 in Age-Related Macular Degeneration

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Wyatt, M Keith ^a,c   Tsai, Jen Yue ^a   Mishra, Sanghamitra ^a   Campos, Maria ^a   Jaworski, Cynthia ^a   Fariss, Robert N ^a   Bernstein, Steven L ^b   Wistow, Graeme ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COMPLEMENT FACTOR H; FIBULIN; FIBULIN 3; UNCLASSIFIED DRUG;

AGED; ARTICLE; BINDING AFFINITY; CHOROID; CONTROLLED STUDY; DRUSEN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; PIGMENT EPITHELIUM; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RETINA MACULA AGE RELATED DEGENERATION;

AGED; CELLS, CULTURED; CHOROID; COMPLEMENT FACTOR H; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOPRECIPITATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RETINAL PIGMENT EPITHELIUM;

EID: 84879541874     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068088     Document Type: Article

References (59)

1. Gehrs KM, Anderson DH, Johnson LV, Hageman GS, (2006) Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann Med 38: 450-471.
2. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, et al. (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20: 705-732.
3. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374.
4. Jarrett SG, Boulton ME, (2012) Consequences of oxidative stress in age-related macular degeneration. Mol Aspects Med 33: 399-417.
5. Sparrow JR, (2010) Bisretinoids of RPE lipofuscin: trigger for complement activation in age-related macular degeneration. Adv Exp Med Biol 703: 63-74.
6. Curcio CA, Johnson M, Rudolf M, Huang JD, (2011) The oil spill in ageing Bruch membrane. Br J Ophthalmol 95: 1638-1645.
7. Klein R, (2007) Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol 14: 184-187.
8. Friedman E, (2000) The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol 130: 658-663.
9. Zarbin MA, (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122: 598-614.
10. Friedlander M, (2007) Fibrosis and diseases of the eye. J Clin Invest 117: 576-586.
11. Kaneko H, Dridi S, Tarallo V, Gelfand BD, Fowler BJ, et al. (2011) DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471: 325-330.
12. Anderson DH, Mullins RF, Hageman GS, Johnson LV, (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134: 411-431.
13. Klein R, Peto T, Bird A, Vannewkirk MR, (2004) The epidemiology of age-related macular degeneration. Am J Ophthalmol 137: 486-495.
14. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, et al. (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99: 14682-14687.
15. Mullins RF, Russell SR, Anderson DH, Hageman GS, (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. Faseb J 14: 835-846.
16. Wang L, Clark ME, Crossman DK, Kojima K, Messinger JD, et al. (2010) Abundant lipid and protein components of drusen. PLoS One 5: e10329.
17. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
18. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. (2005) A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232.
19. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424.
20. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419-421.
21. Hageman GS, Hancox LS, Taiber AJ, Gehrs KM, Anderson DH, et al. (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 38: 592-604.
22. Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, et al. (2006) A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38: 1173-1177.
23. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, et al. (2006) A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314: 992-993.
24. Kanda A, Chen W, Othman M, Branham KE, Brooks M, et al. (2007) A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A 104: 16227-16232.
25. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, et al. (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38: 458-462.
26. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, et al. (2007) Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357: 553-561.
27. Combadiere C, Feumi C, Raoul W, Keller N, Rodero M, et al. (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117: 2920-2928.
28. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, et al. (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 107: 7401-7406.
29. Newman AM, Gallo NB, Hancox LS, Miller NJ, Radeke CM, et al. (2012) Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med 4: 16.
30. Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P, (2004) The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41: 355-367.
31. Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, et al. (2006) Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A 103: 17456-17461.
32. Bhutto IA, Baba T, Merges C, Juriasinghani V, McLeod DS, et al. (2011) C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br J Ophthalmol 95: 1323-1330.
33. Coffey PJ, Gias C, McDermott CJ, Lundh P, Pickering MC, et al. (2007) Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A 104: 16651-16656.
34. Mullins RF, Aptsiauri N, Hageman GS, (2001) Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye (Lond) 15: 390-395.
35. Fritsche LG, Lauer N, Hartmann A, Stippa S, Keilhauer CN, et al. (2010) An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet 19: 4694-4704.
36. Rudolph R, Lilie H, (1996) In vitro folding of inclusion body proteins. Faseb J 10: 49-56.
37. Herbert AP, Deakin JA, Schmidt CQ, Blaum BS, Egan C, et al. (2007) Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J Biol Chem 282: 18960-18968.
38. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM, (1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62: 155-169.
39. Marmorstein LY, Munier FL, Arsenijevic Y, Schorderet DF, McLaughlin PJ, et al. (2002) Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc Natl Acad Sci U S A 99: 13067-13072.
40. Legrain P, Selig L, (2000) Genome-wide protein interaction maps using two-hybrid systems. FEBS Lett 480: 32-36.
41. Timpl R, Sasaki T, Kostka G, Chu ML, (2003) Fibulins: a versatile family of extracellular matrix proteins. Nat Rev Mol Cell Biol 4: 479-489.
42. Klenotic PA, Munier FL, Marmorstein LY, Anand-Apte B, (2004) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations. J Biol Chem 279: 30469-30473.
43. Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U, (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nature Genetics 8: 352-356.
44. Serebriiskii IG, Golemis EA, (2000) Uses of lacZ to study gene function: evaluation of beta-galactosidase assays employed in the yeast two-hybrid system. Anal Biochem 285: 1-15.
45. Sallo FB, Rechtman E, Peto T, Stanescu-Segall D, Vogt G, et al. (2009) Functional aspects of drusen regression in age-related macular degeneration. Br J Ophthalmol 93: 1345-1350.
46. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, et al. (2006) CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet 38: 1049-1054.
47. Laine M, Jarva H, Seitsonen S, Haapasalo K, Lehtinen MJ, et al. (2007) Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol 178: 3831-3836.
48. Prosser BE, Johnson S, Roversi P, Herbert AP, Blaum BS, et al. (2007) Structural basis for complement factor H linked age-related macular degeneration. J Exp Med 204: 2277-2283.
49. Stone EM, Lotery AJ, Munier FL, Heon E, Piguet B, et al. (1999) A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22: 199-202.
50. Fu L, Garland D, Yang Z, Shukla D, Rajendran A, et al. (2007) The R345W Mutation in EFEMP1 is Pathogenic, and Causes AMD-Like Deposits in Mice. Hum Mol Genet.
51. Marmorstein LY, McLaughlin PJ, Peachey NS, Sasaki T, Marmorstein AD (2007) Formation and Progression of Sub-Retinal Pigment Epithelium Deposits in Efemp1 Mutation Knock-in Mice: A Model for the Early Pathogenic Course of Macular Degeneration. Hum Mol Genet.
52. Ono RN, Sengle G, Charbonneau NL, Carlberg V, Bachinger HP, et al. (2009) Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites. J Biol Chem 284: 16872-16881.
53. Stone EM, Braun TA, Russell SR, Kuehn MH, Lotery AJ, et al. (2004) Missense variations in the fibulin 5 gene and age-related macular degeneration. N Engl J Med 351: 346-353.
54. Fisher SA, Rivera A, Fritsche LG, Keilhauer CN, Lichtner P, et al. (2007) Case-control genetic association study of fibulin-6 (FBLN6 or HMCN1) variants in age-related macular degeneration (AMD). Hum Mutat 28: 406-413.
55. Kortvely E, Hauck SM, Duetsch G, Gloeckner CJ, Kremmer E, et al. (2010) ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations. Invest Ophthalmol Vis Sci 51: 79-88.
56. Vierkotten S, Muether PS, Fauser S, (2011) Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components. PLoS ONE 6: e22959.
57. Meyer KJ, Davis LK, Schindler EI, Beck JS, Rudd DS, et al. (2011) Genome-wide analysis of copy number variants in age-related macular degeneration. Hum Genet 129: 91-100.
58. Ding JD, Johnson LV, Herrmann R, Farsiu S, Smith SG, et al. (2011) Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A 108: E279-287.
59. Uno K, Nicholls SJ, (2010) Biomarkers of inflammation and oxidative stress in atherosclerosis. Biomark Med 4: 361-373.